相关实验视频
Updated: Jun 9, 2025

04:33
Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
567
儿童急性和慢性咳中的神经调节剂:文学更新
Simone Foti Randazzese1, Fabio Toscano1, Antonella Gambadauro1
1Pediatric Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Via Consolare Valeria, 1, 98124 Messina, Italy.
International journal of molecular sciences
|October 26, 2024
概括
儿科咳是影响儿童和家庭的常见疾病,可以使用神经调节器来控制. 本综述探讨了它们在通过调节神经通路来治疗咳中的应用.
科学领域:
- 儿科肺病学 儿科肺病学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 咳是儿童常见的疾病,影响生活质量.
- 咳反射涉及一个复杂的神经通路.
- 儿童咳被分为急性 (<4周) 或慢性 (>4周).
研究的目的:
- 审查使用神经调节剂在儿科咳管理中的理由.
- 探索神经调节剂在减少咳频率和严重性的潜力.
- 强调患者选择和监测神经调节器治疗的重要性.
主要方法:
- 对神经调节剂和儿科咳研究的文献综述.
- 对参与咳反射的神经通路的分析.
- 对神经调节器有效性和安全性的临床证据的审查.
主要成果:
- 神经调节剂在治疗儿科咳方面表现出潜力.
- 调节神经通路提供了一个有前途的治疗方法.
- 仔细的患者选择和监测对于最佳结果至关重要.
结论:
- 神经调节剂代表了小儿咳的潜在治疗选择.
- 需要进一步的研究来确定最佳的使用和有效性.
- 这种方法可以改善慢性咳儿童的生活质量.
相关概念视频
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
234
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
234
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
693
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
693
Cholinergic Antagonists: Therapeutic Uses
717
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
717
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Drugs Acting on Autonomic Ganglia: Blockers
967
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
967

